vs

Side-by-side financial comparison of Brookfield Asset Management Ltd. (BAM) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Brookfield Asset Management Ltd. is the larger business by last-quarter revenue ($1.1B vs $719.4M, roughly 1.5× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 56.7%, a 16.5% gap on every dollar of revenue.

Brookfield Asset Management Ltd. is a Canadian-American alternative asset manager. The company was founded in December 2022 as a spin-off of the asset management operations of Brookfield Corporation, and manages investments across real estate, infrastructure, renewable energy, private equity, and credit markets globally.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

BAM vs DOC — Head-to-Head

Bigger by revenue
BAM
BAM
1.5× larger
BAM
$1.1B
$719.4M
DOC
Higher net margin
DOC
DOC
16.5% more per $
DOC
73.2%
56.7%
BAM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BAM
BAM
DOC
DOC
Revenue
$1.1B
$719.4M
Net Profit
$615.0M
$114.0M
Gross Margin
Operating Margin
84.2%
17.4%
Net Margin
56.7%
73.2%
Revenue YoY
3.1%
Net Profit YoY
2406.4%
EPS (diluted)
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAM
BAM
DOC
DOC
Q4 25
$1.1B
$719.4M
Q3 25
$974.0M
$705.9M
Q2 25
$931.0M
$694.3M
Q1 25
$954.0M
$702.9M
Q4 24
$698.0M
Q3 24
$873.0M
$700.4M
Q2 24
$821.0M
$695.5M
Q1 24
$786.0M
$606.6M
Net Profit
BAM
BAM
DOC
DOC
Q4 25
$615.0M
$114.0M
Q3 25
$692.0M
$-117.1M
Q2 25
$584.0M
$31.7M
Q1 25
$507.0M
$42.8M
Q4 24
$4.5M
Q3 24
$537.0M
$85.9M
Q2 24
$124.0M
$146.0M
Q1 24
$373.0M
$6.7M
Gross Margin
BAM
BAM
DOC
DOC
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Q1 24
59.8%
Operating Margin
BAM
BAM
DOC
DOC
Q4 25
84.2%
17.4%
Q3 25
79.1%
9.2%
Q2 25
70.8%
5.7%
Q1 25
61.0%
7.7%
Q4 24
-2.2%
Q3 24
72.5%
14.1%
Q2 24
80.4%
22.3%
Q1 24
56.5%
3.7%
Net Margin
BAM
BAM
DOC
DOC
Q4 25
56.7%
73.2%
Q3 25
71.0%
-16.6%
Q2 25
62.7%
4.6%
Q1 25
53.1%
6.1%
Q4 24
0.7%
Q3 24
61.5%
12.3%
Q2 24
15.1%
21.0%
Q1 24
47.5%
1.1%
EPS (diluted)
BAM
BAM
DOC
DOC
Q4 25
$0.16
Q3 25
$-0.17
Q2 25
$0.05
Q1 25
$0.06
Q4 24
$0.02
Q3 24
$0.12
Q2 24
$0.21
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAM
BAM
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$1.6B
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$8.9B
$7.5B
Total Assets
$17.0B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAM
BAM
DOC
DOC
Q4 25
$1.6B
$467.5M
Q3 25
$1.1B
$91.0M
Q2 25
$480.0M
$89.4M
Q1 25
$332.0M
$70.6M
Q4 24
$119.8M
Q3 24
$180.4M
Q2 24
$10.0M
$106.9M
Q1 24
$101.8M
Total Debt
BAM
BAM
DOC
DOC
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Q1 24
$8.8B
Stockholders' Equity
BAM
BAM
DOC
DOC
Q4 25
$8.9B
$7.5B
Q3 25
$8.5B
$7.6B
Q2 25
$8.5B
$7.9B
Q1 25
$8.5B
$8.2B
Q4 24
$8.4B
Q3 24
$9.0B
$8.6B
Q2 24
$3.2B
$8.8B
Q1 24
$2.2B
$8.9B
Total Assets
BAM
BAM
DOC
DOC
Q4 25
$17.0B
$20.3B
Q3 25
$16.5B
$19.6B
Q2 25
$16.1B
$19.8B
Q1 25
$15.0B
$19.8B
Q4 24
$19.9B
Q3 24
$20.0B
Q2 24
$4.2B
$20.2B
Q1 24
$20.5B
Debt / Equity
BAM
BAM
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAM
BAM
DOC
DOC
Operating Cash FlowLast quarter
$562.0M
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
0.91×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAM
BAM
DOC
DOC
Q4 25
$562.0M
$1.3B
Q3 25
$745.0M
$315.0M
Q2 25
$529.0M
$363.5M
Q1 25
$265.0M
$279.4M
Q4 24
$1.1B
Q3 24
$567.0M
$318.2M
Q2 24
$159.0M
$316.2M
Q1 24
$516.0M
$152.6M
Free Cash Flow
BAM
BAM
DOC
DOC
Q4 25
$357.0M
Q3 25
Q2 25
Q1 25
Q4 24
$333.7M
Q3 24
Q2 24
Q1 24
FCF Margin
BAM
BAM
DOC
DOC
Q4 25
49.6%
Q3 25
Q2 25
Q1 25
Q4 24
47.8%
Q3 24
Q2 24
Q1 24
Capex Intensity
BAM
BAM
DOC
DOC
Q4 25
124.4%
Q3 25
Q2 25
Q1 25
Q4 24
105.6%
Q3 24
Q2 24
Q1 24
Cash Conversion
BAM
BAM
DOC
DOC
Q4 25
0.91×
10.99×
Q3 25
1.08×
Q2 25
0.91×
11.48×
Q1 25
0.52×
6.52×
Q4 24
235.43×
Q3 24
1.06×
3.71×
Q2 24
1.28×
2.17×
Q1 24
1.38×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAM
BAM

Incentive Fees$452.0M42%
Infrastruture$332.0M31%
Private Equity$174.0M16%
Renewable Power And Transition$66.0M6%
Other$47.0M4%
Management And Advisory Fees$14.0M1%

DOC
DOC

Segment breakdown not available.

Related Comparisons